Kinnate Biopharma is recruiting cancer patients who have a solid tumor with BRAF mutation-positive cancers or NRAS mutation-posi
19 Jul 2022, 13:20
Kinnate Biopharma is recruiting cancer patients who have a solid tumor with BRAF mutation-positive cancers or NRAS mutation-positive melanoma.
Please click the link below to learn more information!